Global Friedreich's Ataxia Market Analysis 2023-2034: A Projected $3.39 Billion Opportunity Featuring Strategic Analysis of Reata Pharma, Pfizer, BioMarin Pharma, Retrotope, Voyager Therapeutics, and More
28. Mai 2024 07:00 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Friedreich's Ataxia Market" report has been added to ResearchAndMarkets.com's offering.The global Friedreich's ataxia market accounted for USD...
Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders: 2022-23 Data, Forecasts for 2024- 2026 and CAGR Projections through 2028
22. Dezember 2023 05:03 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders" report has been added to ResearchAndMarkets.com's offering. ...